Courses & Units

Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders CSA726

Hobart

Introduction

CSA726 is a self-directed, fully on-line unit, that explores a variety of disease states and their management, using a series of patient cases linked to assignment based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.

Summary

Unit name Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders
Unit code CSA726
Credit points 12.5
College/School College of Health and Medicine
School of Pharmacy and Pharmacology
Discipline Pharmacy
Coordinator Doctor Mohammed Salahudeen
Teaching staff Ms Naomi Weier
Available as student elective? No
Level Postgraduate

Availability

Location Study period Attendance options Available to
Hobart Semester 1 Off-Campus International Domestic
Hobart Semester 2 Off-Campus International Domestic

Key

On-campus
Off-Campus
International students
Domestic students
Note

Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.

Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.

Key Dates

Study Period Start date Census date WW date End date
Semester 1 21/2/2022 22/3/2022 11/4/2022 29/5/2022
Semester 2 11/7/2022 9/8/2022 29/8/2022 16/10/2022

* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see withdrawal dates explained for more information).

Unit census dates currently displaying for 2022 are indicative and subject to change. Finalised census dates for 2022 will be available from the 1st October 2021.

About Census Dates

Learning Outcomes

  • Identify and evaluate problems associated with psychiatric and neurological medications using an evidence-based approach
  • Critically evaluate psychiatric and neurological medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
  • Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of psychiatric and neurological diseases.
  • Demonstrate effective written and oral presentation skills to explain contemporary issues associated with psychiatric and neurological medication therapy.
Field of Education Commencing Student Contribution 1 Grandfathered Student Contribution 1 Approved Pathway Course Student Contribution 2 Domestic Full Fee
019907 $1,002.00 $1,002.00 not applicable $2,354.00

1 Please refer here more information on student contribution amounts.
2 Information on eligibility and Approved Pathway courses can be found here
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.

Please note: international students should refer to this page to get an indicative course cost.

Requisites

Concurrent Prerequisites

CSA721

Teaching

Teaching Pattern

Online via MyLO and Online tutorial and meeting rooms.

AssessmentQuiz (5%)|Assignment 4 - Presentation (20%)|Assignment 1 - Evidence-based summary (15%)|Assignment 2 - Evidence-based response (25%)|Assignment 3 - Long Clinical Case (35%)
TimetableView the lecture timetable | View the full unit timetable

Textbooks

Required

Required readings will be listed in the unit outline prior to the start of classes.

LinksBooktopia textbook finder

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.